The Prescription vs. OTC Market
The Dry Mouth Relief Market is segmented by type into over-the-counter (OTC) and prescription products. The OTC segment currently holds the largest market share, driven by the wide availability and low cost of products like mouthwashes, gels, and sprays. These products are often the first-line of defense for individuals experiencing mild to moderate dry mouth symptoms. The prescription segment, on the other hand, is a crucial part of the market for patients with more severe or chronic xerostomia, such as those with Sjögren's syndrome or who are undergoing chemotherapy. Prescription medications, such as salivary stimulants like pilocarpine and cevimeline, are highly effective but are only available through a healthcare professional.
The market for both segments is being driven by the continuous need for effective solutions. The OTC segment benefits from consumer self-medication and high accessibility, while the prescription segment is driven by the growing number of diagnosed cases and the need for targeted, long-term treatment. Both are essential for a comprehensive approach to dry mouth management.